REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: -1.00 (-2.38%)
Spread: 2.00 (5.00%)
Open: 42.00
High: 42.00
Low: 41.00
Prev. Close: 42.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM and Directorate Change

15 Dec 2023 14:07

RNS Number : 0306X
Frontier IP Group plc
15 December 2023
 

RNS

AIM: FIPP

15 December 2023

 

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Result of Annual General Meeting and Directorate Change

 

Frontier IP, a specialist in commercialising intellectual property, announces that at its annual general meeting ("AGM"), held earlier today, all resolutions were duly passed with the table below summarising proxy votes received.

The Company also confirms, as announced on 31 October 2023, that Andrew Richmond has not sought re-election as a director at today's annual general meeting and has stepped down from his role as Chairman with effect from today.

Dame Julia King, Baroness Brown of Cambridge has assumed the role of Chair following conclusion of today's AGM.

 

 RESOLUTIONS

NO OF VOTES FOR

% OF VOTES CAST (EXCLUDING VOTES WITHELD)

NO OF VOTES AGAINST

% OF VOTES CAST (EXCLUDING VOTES WITHELD)

TOTAL VOTES CAST (EXCLUDING VOTES WITHHELD)

NO OF VOTES WITHHELD

ORDINARY

1. To receive the audited consolidated financial statements of the Company and its subsidiaries for the year ended 30 June 2023, together with the reports of the Directors and the Auditor thereon.

28,798,831

100%

0

0%

28,798,831

7,001

2. To approve the report of the Board to the members on directors' remuneration for the year ended 30 June 2023.

24,016,521

83%

4,761,258

17%

28,777,779

28,053

3. To re-appoint Neil Crabb as a Director of the Company and, being eligible, is offering himself for reappointment.

28,779,740

100%

3,000

0%

28,782,740

23,092

4. To re-appoint Jacqueline McKay as a Director of the Company and, being eligible, is offering herself for reappointment.

28,779,740

100%

0

0%

28,779,740

26,092

5. To re-appoint James Fish as a Director of the Company and, being eligible, is offering himself for reappointment.

28,779,740

100%

0

0%

28,779,740

26,092

6. To re-appoint Matthew White as a Director of the Company and, being eligible, is offering himself for reappointment.

28,779,740

100%

0

0%

28,779,740

26,092

7. To re-appoint David Holbrook as a Director of the Company and, being eligible, is offering himself for reappointment.

28,779,740

100%

0

0%

28,779,740

26,092

8. To re-appoint Nigel Grierson as a Director of the Company and, being eligible, is offering himself for reappointment

28,779,740

100%

0

0%

28,779,740

26,092

9. To re-appoint Professor Dame Julia King, Baroness Brown of Cambridge as a Director of the Company and, being eligible, is offering herself for reappointment.

28,779,740

100%

0

0%

28,779,740

26,092

10. To resolve not to fill the vacancy created by the retirement of Andrew Richmond as a Director and Chairman of the Company at the AGM, in accordance with the Articles of Association of the Company

28,801,720

100%

0

0%

28,801,720

4,001

11. To re-appoint BDO LLP as auditor of the Company to hold office until the conclusion of the next general meeting at which financial statements are laid before shareholders.

28,797,617

100%

0

0%

28,797,617

8,215

12 To authorise the Directors to determine the auditor's remuneration

28,797,617

100%

4,214

0%

28,801,831

4,001

13. To authorise the directors to allot shares

28,779,740

100%

19,091

0%

28,798,831

7,001

SPECIAL

14. Authority to disapply pre-emption rights in connection with the allotment and issue of equity securities for cash in relation to (i) share option schemes; (ii) rights issue or similar offer; (iii) allotment of equity securities up to 10% of the issued share capital; or (iv) to the allotment of equity securities up to a nominal amount equal to 20%, such authority to be used only for the purposes of making a follow-on offer which the Board of the Company determines to be of a kind contemplated by paragraph 3 of Section 2B of the Statement of Principles on Disapplying Pre-Emption Rights.

23,213,401

81%

5,585,430

19%

28,798,831

7,001

15. Authority to disapply pre-emption rights to allot equity securities for cash.

27,929,775

97%

849,965

3%

28,779,740

26,092

16. Authority to purchase own shares on market.

24,461,860

100%

7,850

0%

24,469,710

4,336,122

 

 

Votes which have been cast at the discretion of the Chairman have been counted as votes for the resolutions. Votes Withheld are not votes in law and do not count in the number of votes counted for or against a resolution.

 

ENQUIRIES

 

Frontier IP Group Plc

Neil Crabb, Chief Executive

 

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

 

T: 020 3968 7815 neil@frontierip.co.uk

 

M: 07464 546 025

andrew.johnson@frontierip.co.uk

 

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

 

T: 0203 328 5656

Singer Capital Markets (Broker)

Harry Gooden / James Fischer

T: 0207 496 3000

 

 

 

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

 

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFFMFLIEDSESE
Date   Source Headline
15th Nov 201812:37 pmRNSGrant of Options
15th Nov 201810:05 amRNSExscientia acquires Kinetic Discovery
15th Nov 20189:30 amRNSPlacing to raise £2.49 million
15th Nov 20189:25 amRNSFinal Results
30th Oct 20187:00 amRNSSecond Portuguese spin out: Des Solutio
19th Oct 20187:00 amRNSMolendotech signs collaboration agreement with G's
5th Oct 20187:00 amRNSDIT hails Frontier IP's Portuguese success
27th Sep 20187:00 amRNSChange of Adviser
26th Sep 20185:12 pmRNSDirector Declaration
24th Sep 20182:30 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSAmprologix to develop new antibiotics with Ingenza
18th Sep 20181:56 pmRNSAlusid raises £1.34m to scale up manufacturing
17th Sep 20187:00 amRNSAB Sugar Head of Innovation joins Frontier IP
30th Aug 201812:39 pmRNSHolding(s) in Company
15th Aug 20187:00 amRNSTVG awarded £50,000 anti-bacterial vaccine grant
7th Aug 20187:00 amRNSPortfolio news - first Portuguese spin out
6th Aug 20187:00 amRNSFieldwork Robotics agreement with Hall Hunter
2nd Aug 20187:00 amRNSFrontier IP partners with UK DIT in Portugal
16th Jul 20187:00 amRNSTarsis Collaboration with Crop-Protection Company
11th Jul 20187:00 amRNSInnovate UK grant for Pulsiv Solar
19th Jun 20187:00 amRNSCambridge Material Testing Solutions
15th May 20187:00 amRNSPalintest launches Molendotech bathing water test
18th Apr 20184:09 pmRNSHolding(s) in Company
9th Apr 20188:25 amRNSIncreased Equity Holding in Fieldwork Robotics
27th Mar 20187:00 amRNSHALF-YEAR RESULTS, 6 MONTHS TO 31 DECEMBER 2017
26th Mar 20187:00 amRNSTeam Expansion and London Office
19th Feb 20187:00 amRNSPortfolio News - Molendotech Secures First Funding
29th Jan 20187:00 amRNSCapital Markets Day
29th Jan 20187:00 amRNSPortfolio News - Molendotech Collaboration
18th Dec 20177:00 amRNSCapital Markets Day
7th Dec 201711:50 amRNSResult of AGM
8th Nov 20177:00 amRNSPosting of Annual Report and Notice of AGM
30th Oct 20175:15 pmRNSHolding(s) in Company
30th Oct 201712:00 pmRNSPortfolio News PulsiV Granted Two US Patents
24th Oct 20177:00 amRNSFinal Results
9th Oct 20177:00 amRNSExscientia Wins Emerging Biotech Company Award
28th Sep 20177:00 amRNSExscientia announces investment from Evotec
25th Sep 20171:12 pmRNSHolding(s) in Company
20th Sep 20177:00 amRNSAlusid extends range at London Design Festival
7th Sep 20177:00 amRNSCSI launches novel sensor system at IFA Berlin
8th Aug 20177:00 amRNSNew Portfolio Company - The Vaccine Group
28th Jul 20173:26 pmRNSHolding(s) in Company
20th Jul 20177:00 amRNSPortfolio News- Nandi Proteins Limited Fundraising
11th Jul 20174:38 pmRNSHolding(s) in Company
5th Jul 20177:00 amRNSNew Portfolio Company - MolEndoTech
3rd Jul 20177:00 amRNSExscientia announces major GSK collaboration
11th May 20177:00 amRNSGrant of Options
9th May 201712:05 pmRNSRoyal Society of Chemistry Nominations
9th May 201711:25 amRNSExscientia announces major Sanofi collaboration
30th Mar 20177:00 amRNSHalf-Year Results for the 6 Months to 31 Dec 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.